Breaking News Bar
updated: 4/16/2014 4:16 PM

Astellas to pay $7.3 million settlement

hello
Success - Article sent! close
 
Associated Press

The U.S. Justice Department announced Wednesday that an Northbrook-based pharmaceutical company will pay $7.3 million to resolve allegations involving the marketing of the drug Mycamine.

Astellas Pharma US Inc. manufactures and sells Mycamine, which is used to treat invasive fungus infections.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

The Justice Department investigated Astellas for alleged off-label promotion of the drug for children between 2005 and 2010. The company has denied the allegation.

The Food and Drug Administration didn't approve the drug for use in children until June 2013.

The federal government will receive $4.2 million and state Medicaid programs will receive $3.1 million.

The company is a subsidiary of Tokyo-based Astellas Pharma.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.